CYTK - CYTOKINETICS INC

QQQ $ 434.88 $ 2.56 (0.59 %)

DIA $ 385.90 $ -0.84 (-0.22 %)

SPY $ 510.08 $ -0.45 (-0.09 %)

TLT $ 89.34 $ -0.75 (-0.83 %)

GLD $ 211.69 $ -1.73 (-0.81 %)

Previous Close

$ 64.34

Open

$ 65.69

Bid

$ 0.00 x 0

Ask

$ 66.18 x 100

Day's Range

$ 65.56 - $ 66.47

52 Week Range

$ 25.98 - $ 110.25

Volume

576,678

Average Volume

Market Cap

6.21B

Beta (5Y Monthly)

$ 0.91

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-28-2024	12-31-2023	10-K
2	11-03-2023	09-30-2023	10-Q
3	08-03-2023	06-30-2023	10-Q
4	05-05-2023	03-31-2023	10-Q
5	03-01-2023	12-31-2022	10-K
6	11-04-2022	09-30-2022	10-Q
7	08-05-2022	06-30-2022	10-Q
8	05-06-2022	03-31-2022	10-Q
9	02-25-2022	12-31-2021	10-K
10	11-05-2021	09-30-2021	10-Q
11	08-06-2021	06-30-2021	10-Q
12	05-07-2021	03-31-2021	10-Q
13	02-26-2021	12-31-2020	10-K
14	11-06-2020	09-30-2020	10-Q
15	08-10-2020	06-30-2020	10-Q
16	05-08-2020	03-31-2020	10-Q
17	03-04-2020	12-31-2019	10-K
18	11-01-2019	09-30-2019	10-Q
19	08-09-2019	06-30-2019	10-Q
20	05-09-2019	03-31-2019	10-Q
21	03-07-2019	12-31-2018	10-K
22	11-09-2018	09-30-2018	10-Q
23	08-07-2018	06-30-2018	10-Q
24	05-10-2018	03-31-2018	10-Q
25	03-05-2018	12-31-2017	10-K
26	11-03-2017	09-30-2017	10-Q
27	08-04-2017	06-30-2017	10-Q
28	05-04-2017	03-31-2017	10-Q
29	03-06-2017	12-31-2016	10-K
30	11-03-2016	09-30-2016	10-Q
31	08-04-2016	06-30-2016	10-Q
32	05-05-2016	03-31-2016	10-Q
33	03-03-2016	12-31-2015	10-K
34	11-05-2015	09-30-2015	10-Q
35	08-05-2015	06-30-2015	10-Q
36	05-04-2015	03-31-2015	10-Q
37	03-06-2015	12-31-2014	10-K
38	11-06-2014	09-30-2014	10-Q
39	08-07-2014	06-30-2014	10-Q
40	05-07-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

cytk---analyzing-cytokineticss-short-interest

(CYTK) - Analyzing Cytokinetics's Short In...
05/01/2024 16:00:21

Cytokinetics To Host Investor Event And Co...
04/29/2024 20:03:36

Cytokinetics, Incorporated (NASDAQ:CYTK) today announced it will host an investor event and conference call on May 13, 2024 at ...

On April 23, Cytokinetics Entered Employm...
04/26/2024 20:08:55

- SEC Filing

Cytokinetics Announces Three Late Breaking...
04/10/2024 11:31:26

Cytokinetics, Incorporated (NASDAQ:CYTK) today announced three Late Breaking Clinical Trial presentations relating to SEQUOIA-H...

Needham Reiterates Buy on Cytokinetics, Ma...
04/09/2024 09:54:38

Needham analyst Serge Belanger reiterates Cytokinetics (NASDAQ:CYTK) with a Buy and maintains $108 price target.

Truist Securities Reiterates Buy on Cytoki...
04/08/2024 15:07:41

Truist Securities analyst Srikripa Devarakonda reiterates Cytokinetics (NASDAQ:CYTK) with a Buy and maintains $86 price target.

Cytokinetics Says It Presented Additional ...
04/05/2024 11:32:22

FOREST-HCM enrolled 213 patients with obstructive HCM from May 28, 2021 through October 31, 2023. Previously presented data fro...

100-invested-in-cytokinetics-5-years-ago-would-be-worth-this-much-today

$100 Invested In Cytokinetics 5 Years Ago ...
04/03/2024 18:00:23

heres-how-much-100-invested-in-cytokinetics-10-years-ago-would-be-worth-today

Here's How Much $100 Invested In Cytokinet...
03/15/2024 15:00:21

JP Morgan Maintains Overweight on Cytokine...
03/07/2024 19:16:05

JP Morgan analyst Tessa Romero maintains Cytokinetics (NASDAQ:CYTK) with a Overweight and lowers the price target from $78 t...

Mizuho Maintains Buy on Cytokinetics, Lowe...
03/06/2024 13:12:00

Mizuho analyst Salim Syed maintains Cytokinetics (NASDAQ:CYTK) with a Buy and lowers the price target from $103 to $99.

Oppenheimer Reiterates Outperform on Cytok...
03/04/2024 13:45:48

Oppenheimer analyst Justin Kim reiterates Cytokinetics (NASDAQ:CYTK) with a Outperform and maintains $107 price target.

unpacking-the-latest-options-trading-trends-in-cytokinetics

Unpacking the Latest Options Trading Trend...
02/28/2024 18:45:47

HC Wainwright & Co. Reiterates Buy on Cyto...
02/28/2024 18:16:39

HC Wainwright & Co. analyst Joseph Pantginis reiterates Cytokinetics (NASDAQ:CYTK) with a Buy and maintains $94 price ta...

Needham Reiterates Buy on Cytokinetics, Ma...
02/28/2024 10:39:19

Needham analyst Serge Belanger reiterates Cytokinetics (NASDAQ:CYTK) with a Buy and maintains $108 price target.

Cytokinetics Anticipates 2024 Revenue Of $...
02/27/2024 22:49:46

The company expects operating expenses will be in the range of $420 to 450 million, and net cash utilization will be approximat...

Cytokinetics Q4 2023 GAAP EPS $(1.38) Miss...
02/27/2024 21:10:59

Cytokinetics (NASDAQ:CYTK) reported quarterly losses of $(1.38) per share which missed the analyst consensus estimate of $(0.97...

heres-how-much-1000-invested-in-cytokinetics-10-years-ago-would-be-worth-today

Here's How Much $1000 Invested In Cytokine...
02/27/2024 18:30:28

Earnings Scheduled For February 27, 2024
02/27/2024 10:01:31

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

Cytokinetics CEO Says "We Have Not Been Co...
02/13/2024 16:18:59

- Oppenheimer 34th Annual Healthcare Life Sciences Conference